fenoldopam has been researched along with Atherosclerosis in 2 studies
Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
Atherosclerosis: A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, Y | 1 |
| Shi, W | 1 |
| Luo, H | 1 |
| Yue, R | 1 |
| Wang, Z | 1 |
| Wang, W | 1 |
| Liu, L | 1 |
| Wang, WE | 1 |
| Wang, H | 1 |
| Zeng, C | 1 |
| Landoni, G | 1 |
| Bignami, E | 1 |
| Gonfalini, M | 1 |
| Mizzi, A | 1 |
| Zangrillo, A | 1 |
2 other studies available for fenoldopam and Atherosclerosis
| Article | Year |
|---|---|
Inhibitory effect of D1-like dopamine receptors on neuropeptide Y-induced proliferation in vascular smooth muscle cells.
Topics: Animals; Atherosclerosis; Cell Proliferation; Cyclic AMP-Dependent Protein Kinases; Fenoldopam; Male | 2015 |
Fenoldopam in cardiac surgery-associated acute kidney injury.
Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Aortic Diseases; Atherosclerosis; Blo | 2008 |